JP2025501967A5 - - Google Patents

Info

Publication number
JP2025501967A5
JP2025501967A5 JP2024539654A JP2024539654A JP2025501967A5 JP 2025501967 A5 JP2025501967 A5 JP 2025501967A5 JP 2024539654 A JP2024539654 A JP 2024539654A JP 2024539654 A JP2024539654 A JP 2024539654A JP 2025501967 A5 JP2025501967 A5 JP 2025501967A5
Authority
JP
Japan
Prior art keywords
group
compound
salt
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024539654A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501967A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/143074 external-priority patent/WO2023125738A1/zh
Publication of JP2025501967A publication Critical patent/JP2025501967A/ja
Publication of JP2025501967A5 publication Critical patent/JP2025501967A5/ja
Pending legal-status Critical Current

Links

JP2024539654A 2021-12-29 2022-12-29 送達のための脂質及び組成物 Pending JP2025501967A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202111638123 2021-12-29
CN202111638123.4 2021-12-29
CN202210651178 2022-06-09
CN202210651178.7 2022-06-09
PCT/CN2022/143074 WO2023125738A1 (zh) 2021-12-29 2022-12-29 用于递送的脂质和组合物

Publications (2)

Publication Number Publication Date
JP2025501967A JP2025501967A (ja) 2025-01-24
JP2025501967A5 true JP2025501967A5 (cg-RX-API-DMAC7.html) 2026-01-14

Family

ID=86998079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024539654A Pending JP2025501967A (ja) 2021-12-29 2022-12-29 送達のための脂質及び組成物

Country Status (10)

Country Link
US (1) US20250064750A1 (cg-RX-API-DMAC7.html)
EP (1) EP4458806A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025501967A (cg-RX-API-DMAC7.html)
KR (1) KR20240128984A (cg-RX-API-DMAC7.html)
CN (1) CN120476106A (cg-RX-API-DMAC7.html)
AU (1) AU2022424144A1 (cg-RX-API-DMAC7.html)
CA (1) CA3242974A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024007242A (cg-RX-API-DMAC7.html)
TW (1) TW202330458A (cg-RX-API-DMAC7.html)
WO (1) WO2023125738A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4582409A4 (en) * 2022-09-19 2026-06-03 Suzhou Suncadia Biopharmaceuticals Co Ltd PROCESS FOR PREPARING A 2-HYDROXYETHYL AMINOCAPROATE COMPOUND AND ITS USE
EP4736848A1 (en) 2023-06-28 2026-05-06 Shanghai Regenelead Therapies Co., Ltd. Pharmaceutical composition containing cationic lipid and use thereof
TW202532107A (zh) 2023-11-14 2025-08-16 大陸商上海瑞宏迪醫藥有限公司 一種含核酸構建體的醫藥組成物及其醫藥用途
WO2025103414A1 (zh) 2023-11-14 2025-05-22 上海瑞宏迪医药有限公司 一种脂质纳米粒的制备方法和应用
WO2025124548A1 (zh) 2023-12-13 2025-06-19 上海瑞宏迪医药有限公司 一种咪唑类脂质及其应用
AU2024401929A1 (en) 2023-12-13 2026-05-28 Shanghai Regenelead Therapies Co., Ltd. Cationic lipid and use thereof
WO2025124560A1 (zh) 2023-12-13 2025-06-19 上海瑞宏迪医药有限公司 用于递送治疗剂的组合物和化合物
CN119019272A (zh) * 2024-08-14 2024-11-26 中国药科大学 可电离脂质、包含其的组合物及其用途
CN119191996A (zh) * 2024-11-28 2024-12-27 浙江省质量科学研究院 一种双羟乙基氨基丙基羟乙基油胺的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
CN108368028B (zh) * 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
WO2020219876A1 (en) 2019-04-25 2020-10-29 Intellia Therapeutics, Inc. Ionizable amine lipids and lipid nanoparticles
CN114763324A (zh) * 2021-01-15 2022-07-19 纳肽得(青岛)生物医药有限公司 一种脂质化合物及脂质体与药物组合物
CN113264842B (zh) * 2021-07-21 2022-03-01 苏州科锐迈德生物医药科技有限公司 一种脂质化合物及包含其的脂质载体、核酸脂质纳米粒组合物和药物制剂
CN114773217B (zh) * 2022-06-20 2022-10-18 深圳市瑞吉生物科技有限公司 用于递送核酸的阳离子脂质化合物和组合物及用途

Similar Documents

Publication Publication Date Title
AU2023201644B2 (en) Lipid nanoparticles
JP2022529370A5 (cg-RX-API-DMAC7.html)
JP2010509373A5 (cg-RX-API-DMAC7.html)
EP4269385A1 (en) Ionizable lipid compounds
JP2020531418A5 (cg-RX-API-DMAC7.html)
WO2017222016A1 (ja) カチオン性脂質
HRP20220268T1 (hr) Spojevi i pripravci za unutarstaničnu isporuku sredstava
JP2023549226A5 (cg-RX-API-DMAC7.html)
JP2018514544A5 (cg-RX-API-DMAC7.html)
TW202106304A (zh) 盧梭利替尼之緩釋性劑型
CA2893959A1 (en) Pharmaceutical compositions
EP4729509A1 (en) Ionizable lipid for muscle-specific delivery
KR20250039418A (ko) 아미노 지질 화합물, 그의 제조 방법 및 그의 용도
EP3075739A1 (en) A pentacyclic triterpenoid compound with modified structure and preparation method and use thereof
JP2007522162A5 (cg-RX-API-DMAC7.html)
CA2631581A1 (en) Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
CN120359199A (zh) 新型化合物及其靶向递送用途
JP2022537964A5 (cg-RX-API-DMAC7.html)
CN115337267A (zh) 一种基于脂质体纳米囊泡的酸响应型药物递送平台的制备方法及其应用
WO2023089522A1 (en) Novel lipids for delivery of nucleic acid segments
JP2024533182A5 (cg-RX-API-DMAC7.html)
CN117800859A (zh) 具有戊二酸骨架的脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂
JP2024536718A5 (cg-RX-API-DMAC7.html)
CA2883791A1 (en) Bolaamphiphilic compounds, compositions and uses thereof
CA3114462A1 (en) Quinone reductase 2 inhibitor compounds and uses thereof